Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.
Rocchetti M, et al. Among authors: sala l.
Cardiovasc Res. 2014 Oct 1;104(1):37-48. doi: 10.1093/cvr/cvu188. Epub 2014 Aug 18.
Cardiovasc Res. 2014.
PMID: 25139747